Samal Pallavi, Satpathy Siddharth, Panigrahi Lipsa Leena, Jha Suman, Arakha Manoranjan
Centre for Biotechnology, Siksha 'O' Anusandhan (Deemed to be University), Bhubaneswar, 751003, Odisha, India.
Department of Life Science, National Institute of Technology Rourkela, Odisha 769008, India.
Nanoscale Horiz. 2025 Jul 21;10(8):1615-1641. doi: 10.1039/d5nh00076a.
The protein and nanoparticle interaction is the basis of nanoparticle bio-reactivity. Nanoparticles upon interaction with proteins form a protein corona, altering their characteristics. This corona influences nanoparticles' biodistribution, pharmacokinetics, and therapeutic efficacy. The complex protein-nanoparticle interactions have a significant impact on the emergence of chronic inflammation and chronic diseases. This study is a comprehensive review that explores the dynamic nature of protein-nanoparticle interactions, emphasizing their long-term effects on sustained inflammatory responses and subsequent implications for various chronic conditions, and not an exhaustive review of all aspects. This study investigates the role of nanoparticle characteristics such as the size, shape, and surface charge in the formation of a protein corona, addressing the molecular aspects and cellular pathways involved. The connection between protein-nanoparticle interactions and chronic inflammation is deeply explored in the context of specific diseases, including cardiovascular disorders, neurological conditions, respiratory ailments, metabolic disorders, autoimmune conditions, and cancer. Insights from and clinical studies, coupled with discussions on genotoxicity, immunotoxicity, and mitigation strategies, contribute to a deeper understanding of the broader implications of these interactions. Nevertheless, this serves as a foundational framework for grasping the pivotal advancements and breakthroughs achieved recent novel perspectives concerning the advanced methodologies for investigating protein-nanoparticle interaction and its correlation with chronic diseases. Additionally, this endeavour seeks to identify existing knowledge gaps demanding thorough exploration and offers insights for enhancing our knowledge of the interplay between protein-nanoparticle interactions and chronic disease pathogenesis. By addressing ethical considerations and public perceptions, this review outlines future research directions, highlighting the importance of extending our understanding of the safe and effective integration of nanotechnology into a broad range of applications.
蛋白质与纳米颗粒的相互作用是纳米颗粒生物反应性的基础。纳米颗粒与蛋白质相互作用后会形成蛋白质冠层,从而改变其特性。这种蛋白质冠层会影响纳米颗粒的生物分布、药代动力学和治疗效果。复杂的蛋白质 - 纳米颗粒相互作用对慢性炎症和慢性疾病的发生具有重大影响。本研究是一项全面综述,探讨蛋白质 - 纳米颗粒相互作用的动态性质,强调其对持续炎症反应的长期影响以及对各种慢性疾病的后续影响,而非对所有方面的详尽综述。本研究调查了纳米颗粒特性(如尺寸、形状和表面电荷)在蛋白质冠层形成中的作用,涉及相关分子层面和细胞途径。在包括心血管疾病、神经系统疾病、呼吸系统疾病、代谢紊乱、自身免疫性疾病和癌症等特定疾病背景下,深入探讨了蛋白质 - 纳米颗粒相互作用与慢性炎症之间的联系。来自[相关研究]和临床研究的见解,以及关于遗传毒性、免疫毒性和缓解策略的讨论,有助于更深入地理解这些相互作用的更广泛影响。然而,这为理解近期关于研究蛋白质 - 纳米颗粒相互作用及其与慢性疾病相关性的先进方法所取得的关键进展和突破提供了一个基础框架。此外,这项工作旨在识别需要深入探索的现有知识空白,并为增进我们对蛋白质 - 纳米颗粒相互作用与慢性疾病发病机制之间相互作用的认识提供见解。通过考虑伦理因素和公众认知,本综述概述了未来的研究方向,强调了扩展我们对纳米技术安全有效整合到广泛应用中的理解的重要性。